Based on bone marrow morphological characteristics, SF3B1 negativity, temporal drug exposure correlation, and rapid hematologic recovery post-cessation, clonal myeloid disorders such as MDS-RS were excluded, with drug-induced erythropoietic dysfunction concomitant with secondary iron metabolism abnormalities being established. Here, SF3B1 is linked to myelodysplastic syndrome.